GB9103824D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB9103824D0
GB9103824D0 GB919103824A GB9103824A GB9103824D0 GB 9103824 D0 GB9103824 D0 GB 9103824D0 GB 919103824 A GB919103824 A GB 919103824A GB 9103824 A GB9103824 A GB 9103824A GB 9103824 D0 GB9103824 D0 GB 9103824D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919103824A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FISONS AG
Original Assignee
FISONS AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB919103824A priority Critical patent/GB9103824D0/en
Application filed by FISONS AG filed Critical FISONS AG
Publication of GB9103824D0 publication Critical patent/GB9103824D0/en
Priority to IE051692A priority patent/IE920516A1/en
Priority to GR920100064A priority patent/GR1001511B/en
Priority to IL101010A priority patent/IL101010A0/en
Priority to PCT/GB1992/000290 priority patent/WO1992014473A1/en
Priority to AU12471/92A priority patent/AU1247192A/en
Priority to ZA921247A priority patent/ZA921247B/en
Priority to ITMI920393A priority patent/IT1254627B/en
Priority to BE9200182A priority patent/BE1004177A4/en
Priority to MX9200748A priority patent/MX9200748A/en
Priority to PT100150A priority patent/PT100150A/en
Priority to CN92101619A priority patent/CN1065010A/en
Priority to FR9202105A priority patent/FR2673104A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
GB919103824A 1991-02-23 1991-02-23 Formulation Pending GB9103824D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation
IE051692A IE920516A1 (en) 1991-02-23 1992-02-18 Steroid Formulations
GR920100064A GR1001511B (en) 1991-02-23 1992-02-18 Steroid formulations.
IL101010A IL101010A0 (en) 1991-02-23 1992-02-19 Steroid pharmaceutical formulations
PCT/GB1992/000290 WO1992014473A1 (en) 1991-02-23 1992-02-19 Steroid formulations
AU12471/92A AU1247192A (en) 1991-02-23 1992-02-19 Steroid formulations
ZA921247A ZA921247B (en) 1991-02-23 1992-02-20 Steroid formulations
ITMI920393A IT1254627B (en) 1991-02-23 1992-02-21 Steroid formulations
PT100150A PT100150A (en) 1991-02-23 1992-02-21 FORMULATIONS CONTAINING STEROIDS
BE9200182A BE1004177A4 (en) 1991-02-23 1992-02-21 Steroid compositions.
MX9200748A MX9200748A (en) 1991-02-23 1992-02-21 STEROID FORMULATIONS. STEROID FORMULATIONS.
CN92101619A CN1065010A (en) 1991-02-23 1992-02-22 The compositions of steroid
FR9202105A FR2673104A1 (en) 1991-02-23 1992-02-24 PHARMACEUTICAL COMPOSITIONS OF AQUEOUS SUSPENDED ANTI-INFLAMMATORY STEROUID FOR NASAL ADMINISTRATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation

Publications (1)

Publication Number Publication Date
GB9103824D0 true GB9103824D0 (en) 1991-04-10

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919103824A Pending GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation

Country Status (13)

Country Link
CN (1) CN1065010A (en)
AU (1) AU1247192A (en)
BE (1) BE1004177A4 (en)
FR (1) FR2673104A1 (en)
GB (1) GB9103824D0 (en)
GR (1) GR1001511B (en)
IE (1) IE920516A1 (en)
IL (1) IL101010A0 (en)
IT (1) IT1254627B (en)
MX (1) MX9200748A (en)
PT (1) PT100150A (en)
WO (1) WO1992014473A1 (en)
ZA (1) ZA921247B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (en) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc Aqueous pharmacological composition
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
AR026072A1 (en) * 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION
DE10064950A1 (en) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropic nasal spray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
US20210220378A1 (en) * 2017-10-11 2021-07-22 Lifescience As N-acetylneuraminic acid compositions and methods of use
WO2020165578A1 (en) * 2019-02-11 2020-08-20 Reckitt Benckiser Health Limited Novel composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Aerosol propellant compositions

Also Published As

Publication number Publication date
FR2673104A1 (en) 1992-08-28
CN1065010A (en) 1992-10-07
WO1992014473A1 (en) 1992-09-03
ITMI920393A1 (en) 1993-08-21
IL101010A0 (en) 1992-11-15
GR1001511B (en) 1994-02-28
PT100150A (en) 1993-05-31
IE920516A1 (en) 1992-08-26
BE1004177A4 (en) 1992-10-06
MX9200748A (en) 1992-10-01
ZA921247B (en) 1992-10-28
ITMI920393A0 (en) 1992-02-21
AU1247192A (en) 1992-09-15
IT1254627B (en) 1995-09-28

Similar Documents

Publication Publication Date Title
GB9118028D0 (en) Improved transdrmal formulations
GB9207832D0 (en) Formulations
GB9103824D0 (en) Formulation
GB9119102D0 (en) Bioimmunassay
ZA937714B (en) Novel formulation
GB9124169D0 (en) Alldrive
GB9108128D0 (en) Novel formulation
GB9120675D0 (en) Formulation
GB9125953D0 (en) Formulation
GB9108281D0 (en) Formulation
GB9104946D0 (en) Formulation
GB9126687D0 (en) Novel formulation
GB9025762D0 (en) Formulation
GB9012919D0 (en) Formulation
GB9011851D0 (en) Formulation
ZW10390A1 (en) Formulation
GB9008591D0 (en) Formulation
GB9003965D0 (en) Formulation
ZA928061B (en) Lipomimetic formulation
GB9202110D0 (en) Formulation
GB9201915D0 (en) Formulation
GB9217322D0 (en) Formulation
GB9225583D0 (en) Formulation
GB9205183D0 (en) Formulation
GB9105386D0 (en) Formulations